Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | F9 | P00740 | 3/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.33 |
| ▸ | PIM3 | Q86V86 | 2/20 | 0.32 |
| ▸ | PIM1 | P11309 | 1/20 | 0.32 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.30 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.30 |
| ▸ | TNKS | O95271 | 1/20 | 0.30 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23313488 | 0.98 | F9 (0.37) | ALOX5F9CA12CA1CA2 | |
| SCHEMBL23313486 | 0.94 | F9 (0.37) | ALOX5F9CA12CA1CA2 | |
| SCHEMBL23238038 | 0.94 | ALOX5 (0.42) | ALOX5F9CA12CA1CA2 | |
| SCHEMBL25824142 | 0.94 | ALOX5 (0.42) | ALOX5F9CA12CA1CA2 | |
| SCHEMBL23239190 | 0.93 | ALOX5 (0.40) | ALOX5F9CA12CA1CA2 | |
| SCHEMBL23313719 | 0.92 | F9 (0.39) | ALOX5F9CA12CA1CA2 | |
| SCHEMBL23313379 | 0.92 | ALOX5 (0.43) | ALOX5F9CA12CA1CA2 | |
| SCHEMBL24919415 | 0.92 | ALOX5 (0.40) | ALOX5F9CA12CA1CA2 | |
| SCHEMBL23313563 | 0.92 | ALOX5 (0.39) | ALOX5F9LIMK1PIM3PIM1 | |
| SCHEMBL23313335 | 0.92 | ALOX5 (0.44) | ALOX5F9CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210126197-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND AMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210126197-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND AMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | PIEZO1, L1CAM, AOC1 | ALOX5 1383/4885F9 1752/4885CA12 2457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.